Australia, Sept. 25 -- RayzeBio Inc., owns the trademark (2566622) for 'ACSSTRIVO' till July 14, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical and biological preparations for human use.] and 5 [Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders;diagnostic radiopharmaceutical preparations.]
Type of Mark: Word
Date of Acceptance: July 17
Registration Advertised: Sept. 24
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2566622.
Disclaimer: Curated by HT Syndication.
